InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c
Tweet
Share
E-mailGet Alerts inm Hot Sheet
Join SI Premium – FREE
InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.
For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- UBS Upgrades Lovisa Holdings Ltd (LOV:AU) to Buy
- Draganfly wins Canadian Armed Forces drone contract for up to 5,000 units
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
